MedicalResearch.com Interview with: Xin Li, Ph.D.
Department of Veterinary Biosciences
The Ohio State University
344 Veterinary Medicine Academic Building
Columbus, OH 43210
MedicalResearch.com: What are the main findings of the study?Dr. Xin Li :Antibody responses to borrelial antigens that are primarily expressed during the tick phase the spirochetes’ life cycle are common in American patients with Lyme arthritis, a late-stage manifestation of Lyme borreliosis, but are rare in American patients with early-stage infection or European patients with early- or late-stage infection.
MedicalResearch.com Interview with Dr. H. Irene Hall, PhD
Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention,
1600 Clifton Road, MS E-47, Atlanta, GA 30333
MedicalResearch.com: What are the main findings of the study?Dr. Hall: Our research finds that, across all populations, far too few Americans with HIV receive the care they need to stay healthy and reduce risk of transmission. According to our research, gaps in care are the largest among African Americans and young people. Moving forward, improving care for all HIV-infected people will be critical to achieving the goal of an AIDS-free generation in America.
More specifically, some of the key findings of the study include:
Overall, only a quarter of all Americans with HIV have a suppressed viral load – meaning the level of HIV in their bodies is low enough to stay healthy and dramatically reduce the chance of transmitting to others.
By race/ethnicity, African-Americans and Hispanics or Latinos are less likely to be aware of their infection compared to whites.
By age, younger Americans are less likely to be in ongoing care and have a suppressed viral load; HIV care and viral suppression generally improved with age. For example:
Fifteen percent of those aged 25-34 were virally suppressed, compared to 36 percent of those aged 55-64.
In terms of ongoing care, 28 percent of those 25-34 years old were retained in care, compared to 46 percent of those aged 55-64.
MedicalResearch.com Interview with: Marin L. Schweizer Ph.D.
University of Iowa Carver College of Medicine
Iowa City, IA, USA
MedicalResearch.com: What are the main findings of the study?Dr. Schweizer: A clinical bundle that includes nasally screening cardiac and orthopedic surgery patients for S. aureus (both methicillin-resistant S. aureus and methicillin-susceptible S. aureus), decolonizing carriers, and changing antibiotic prophylaxis for MRSA carriers, can significantly reduce the number of gram-positive surgical site infections, S. aureus surgical site infections and MRSA surgical site infections.
MedicalResearch.com eInterview with: Dr. Reena Pattani MD
Department of Medicine
St. Michael’s Hospital
30 Bond Street, Toronto ON M5B 1W8
MedicalResearch.com: What are the main findings of the study?Dr. Pattani:We performed a meta-analysis of 16 studies that assessed the effectiveness of probiotics administered concurrently with antibiotics compared to the use of antibiotics alone. The use of probiotics among patients in these trials reduced the risk of antibiotic-associated diarrhea by almost 40% and decreased the rate of Clostridium difficile infection by 63%. On subgroup analysis, the reduction remained statistically significant for the subgroups of good quality trials, trials in which a primarily Lactobacillus-based regimen was used, and those studies which had a follow-up period of less than 4 weeks.
Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control,
Jiangsu provincial center for disease prevention and control
MedicalResearch.com Editor's Note:
Hand Foot and Mouth Disease
MedicalResearch.com: What are the main findings of the study?
Answer: From this trial, the inactivated alum-adjuvant EV71 vaccine showed a good protection for both the EV71-associated HFMD and EV71-associated disease. The vaccine gave 90% protection against clinical EV71-associated HFMD and 80.4% against EV71-associated disease (including neurological complications) for at least 12 months. The safety profile and immunogenicity of this vaccine is proved to be clinical acceptable. We also proposed a titre (1:32) of neutralization antibody as surrogate of protection against EV71-associated disease.
MedicalResearch.com Author Interview: Dr.Donald K. Milton, MD, Dr.P.HDr. Donald K. Milton, MD, Dr.P.HProfessor and DirectorMaryland Institute for Applied Environmental Health
University of Maryland
MedicalResearch.com: What are the main findings of the study?Dr. Milton: We found that total viral copies detected by molecular methods were 8.8 times more numerous in fine (≤5 µm) than in coarse (>5 µm) aerosol particles and that the fine particles from cases with the highest total number of viral RNA copies contained infectious virus.
Surgical masks reduced the overall number of RNA copies by 3.4 fold.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.